Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption
- PMID: 12568403
- DOI: 10.1359/jbmr.2003.18.2.260
Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption
Abstract
Interleukin (IL)-1 is implicated in postmenopausal- and inflammation-mediated bone loss. Its expression is regulated by NF-kappaB and vice versa. To examine the role of NF-kappaB p50 and p52 (they are required for osteoclast formation during embryonic development) in IL-1-induced resorption, we used various NF-kappaB knockout (KO) mice, including p50-/- and p52-/- single KO, p50-/- and p52+/- (3/4KO), and p50-/- and p52-/- double KO (dKO) mice. IL-1 increased blood calcium and bone resorption in wild-type (wt), p50, and p52 single KO mice, but not in 3/4KO or dKO mice. Osteoclast formation was impaired in bone marrow cultures from 3/4KO compared with single KO and wt mice treated with IL-1. IL-1 receptor expression was similar in colony forming unit-granulocyte macrophage (CFU-GM) colony cells from wt and dKO mice. However, IL-1 promoted CFU-GM colony formation and survival as well as the formation, activity, and survival of osteoclasts generated from these colonies from wt mouse splenocytes, but not from dKO splenocytes. No difference in expression of the osteoclast regulatory cytokines, RANKL, and OPG, was observed in osteoblasts from wt and dKO mice. Thus, expression of either NF-kappaB p50 or p52 is required in osteoclasts and their precursors, rather than osteoblasts, for IL-1-mediated bone resorption.
Similar articles
-
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.J Bone Miner Res. 2002 Jul;17(7):1200-10. doi: 10.1359/jbmr.2002.17.7.1200. J Bone Miner Res. 2002. PMID: 12096833
-
Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.J Bone Miner Res. 2004 Nov;19(11):1905-16. doi: 10.1359/JBMR.040919. Epub 2004 Sep 27. J Bone Miner Res. 2004. PMID: 15476591
-
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.J Bone Miner Res. 2000 Aug;15(8):1459-66. doi: 10.1359/jbmr.2000.15.8.1459. J Bone Miner Res. 2000. PMID: 10934644
-
RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.Cancer. 2003 Feb 1;97(3 Suppl):802-12. doi: 10.1002/cncr.11134. Cancer. 2003. PMID: 12548579 Review.
-
Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands.Cytokine Growth Factor Rev. 2001 Mar;12(1):9-18. doi: 10.1016/s1359-6101(00)00030-7. Cytokine Growth Factor Rev. 2001. PMID: 11312114 Review.
Cited by
-
Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis.Cancers (Basel). 2021 Mar 19;13(6):1411. doi: 10.3390/cancers13061411. Cancers (Basel). 2021. PMID: 33808757 Free PMC article. Review.
-
Use of cell permeable NBD peptides for suppression of inflammation.Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii75-82. doi: 10.1136/ard.2006.058438. Ann Rheum Dis. 2006. PMID: 17038479 Free PMC article. Review.
-
NF-κB-Mediated Regulation of Osteoclastogenesis.Endocrinol Metab (Seoul). 2015 Mar 27;30(1):35-44. doi: 10.3803/EnM.2015.30.1.35. Endocrinol Metab (Seoul). 2015. PMID: 25827455 Free PMC article. Review.
-
Regulation of osteoclast-mediated bone resorption by microRNA.Cell Mol Life Sci. 2022 May 10;79(6):287. doi: 10.1007/s00018-022-04298-y. Cell Mol Life Sci. 2022. PMID: 35536437 Free PMC article. Review.
-
NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.J Clin Invest. 2009 Oct;119(10):3024-34. doi: 10.1172/JCI38716. Epub 2009 Sep 21. J Clin Invest. 2009. PMID: 19770515 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
